These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31417958)

  • 61. Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study.
    Nowacki M; Alyami M; Villeneuve L; Mercier F; Hubner M; Willaert W; Ceelen W; Reymond M; Pezet D; Arvieux C; Khomyakov V; Lay L; Gianni S; Zegarski W; Bakrin N; Glehen O
    Eur J Surg Oncol; 2018 Jul; 44(7):991-996. PubMed ID: 29526367
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
    Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
    [No Abstract]   [Full Text] [Related]  

  • 63. Strategy for Oligometastatic Recurrence of Cardia Adenocarcinoma: Liver Radiofrequency Ablation Associated with PIPAC Inducing Response Permitting Cytoreductive Surgery and HIPEC.
    Platevoet P; Doat S; Bachet JB; Maingon P; Savier É; Vaillant JC; Pocard M
    Indian J Surg Oncol; 2023 Jun; 14(Suppl 1):122-126. PubMed ID: 37359926
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pressurized Intraperitoneal Aerosol Chemotherapy-Related Clinical Trials in the Treatment of Peritoneal Metastases.
    Ukegjini K; Putora PM; Guidi M; Süveg K; Cihoric N; Widmann B; Steffen T
    Oncology; 2021; 99(9):601-610. PubMed ID: 34265774
    [TBL] [Abstract][Full Text] [Related]  

  • 65. PIPAC in patients with peritoneal metastases from gastrointestinal tract (PIPOX01): An open label, non-comparative phase 1/2 dose escalation and expansion trial.
    Dumont F; Kepenekian V; Passot C; Ezanno-Manasterski AC; Pocard M; Raoul JL; Lelièvre B; Hiret S; Senellart H; Pein F; Raimbourg J; Campion L; Thibaudeau E; Paul J; Glehen O;
    Eur J Surg Oncol; 2024 Jun; 50(9):108468. PubMed ID: 38878757
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II).
    Koemans WJ; van der Kaaij RT; Boot H; Buffart T; Veenhof AAFA; Hartemink KJ; Grootscholten C; Snaebjornsson P; Retel VP; van Tinteren H; Vanhoutvin S; van der Noort V; Houwink A; Hahn C; Huitema ADR; Lahaye M; Los M; van den Barselaar P; Imhof O; Aalbers A; van Dam GM; van Etten B; Wijnhoven BPL; Luyer MDP; Boerma D; van Sandick JW
    BMC Cancer; 2019 May; 19(1):420. PubMed ID: 31060544
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Systemic Treatment of Malignant Pleural Mesothelioma].
    Nakano T
    Gan To Kagaku Ryoho; 2017 Dec; 44(13):2041-2047. PubMed ID: 29361614
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal carcinomatosis: systematic review of clinical and experimental evidence with special emphasis on ovarian cancer.
    Tempfer C; Giger-Pabst U; Hilal Z; Dogan A; Rezniczek GA
    Arch Gynecol Obstet; 2018 Aug; 298(2):243-257. PubMed ID: 29869089
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial.
    Glockzin G; Rochon J; Arnold D; Lang SA; Klebl F; Zeman F; Koller M; Schlitt HJ; Piso P
    BMC Cancer; 2013 Feb; 13():67. PubMed ID: 23391248
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial.
    Beeharry MK; Ni ZT; Yang ZY; Zheng YN; Feng RH; Liu WT; Yan C; Yao XX; Li C; Yan M; Zhu ZG
    BMC Cancer; 2020 Mar; 20(1):224. PubMed ID: 32183736
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Malignant Peritoneal Mesothelioma: National Practice Patterns, Outcomes, and Predictors of Survival.
    Verma V; Sleightholm RL; Rusthoven CG; Koshy M; Sher DJ; Grover S; Simone CB
    Ann Surg Oncol; 2018 Jul; 25(7):2018-2026. PubMed ID: 29721724
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-OX) in patients with colorectal peritoneal metastases-a systematic review.
    Lurvink RJ; Rovers KP; Nienhuijs SW; Creemers GJ; Burger JWA; de Hingh IHJ
    J Gastrointest Oncol; 2021 Apr; 12(Suppl 1):S242-S258. PubMed ID: 33968441
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Recent Advances in Intra-peritoneal Chemotherapy for Gastric Cancer.
    Chia DKA; So JBY
    J Gastric Cancer; 2020 Jun; 20(2):115-126. PubMed ID: 32595996
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial.
    Grosso F; Steele N; Novello S; Nowak AK; Popat S; Greillier L; John T; Leighl NB; Reck M; Taylor P; Planchard D; Sørensen JB; Socinski MA; von Wangenheim U; Loembé AB; Barrueco J; Morsli N; Scagliotti G
    J Clin Oncol; 2017 Nov; 35(31):3591-3600. PubMed ID: 28892431
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Overcoming Drug Resistance by Taking Advantage of Physical Principles: Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC).
    Nadiradze G; Horvath P; Sautkin Y; Archid R; Weinreich FJ; Königsrainer A; Reymond MA
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31877647
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): The First Reported Case in Brazil Using Standardized Technique with the Capnopen® Nebulizer Device.
    Akaishi EH; Vaz da Silva DG; Lima HVG; Grapperon-Mathis RLM; Arakaki MS; Galindo IVA; Daia LA; Araruna GF; Oliveira ALT; Mancini CN; Hoff PMG
    Am J Case Rep; 2021 Nov; 22():e933906. PubMed ID: 34725317
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Review of management and treatment of peritoneal metastases from gastric cancer origin.
    Manzanedo I; Pereira F; Serrano Á; Pérez-Viejo E
    J Gastrointest Oncol; 2021 Apr; 12(Suppl 1):S20-S29. PubMed ID: 33968423
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Number of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Treatments is Associated with Longer Survival: Analysis of a Large Prospective Cohort of Patients With Unresectable Peritoneal Surface Malignancies.
    Orgad R; Bakrin N; Bonnefoy I; Villeneuve L; Alyami M; Alhadeedi O; Glehen O; Kepenekian V
    Ann Surg; 2024 Jul; ():. PubMed ID: 39041212
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma.
    Krug LM; Wozniak AJ; Kindler HL; Feld R; Koczywas M; Morero JL; Rodriguez CP; Ross HJ; Bauman JE; Orlov SV; Ruckdeschel JC; Mita AC; Fein L; He X; Hall R; Kawabe T; Sharma S
    Lung Cancer; 2014 Sep; 85(3):429-34. PubMed ID: 25047675
    [TBL] [Abstract][Full Text] [Related]  

  • 80. JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma.
    Miyamoto Y; Kozuki T; Aoe K; Wada S; Harada D; Yoshida M; Sakurai J; Hotta K; Fujimoto N
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34711664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.